Literature DB >> 15304580

Dementia in hippocampal sclerosis resembles frontotemporal dementia more than Alzheimer disease.

D M Blass1, K J Hatanpaa, J Brandt, V Rao, M Steinberg, J C Troncoso, P V Rabins.   

Abstract

OBJECTIVE: To characterize the clinical course of pathologically diagnosed hippocampal sclerosis dementia (HSD).
BACKGROUND: Dementia associated with HSD is incompletely characterized. Previous studies suggest similarities to both Alzheimer disease (AD) and frontotemporal dementia (FTD).
METHODS: Case-control analysis of the clinical course of patients with HSD, FTD, and AD from a neuropathology autopsy series conducted by a university hospital. Case histories were reviewed. Cumulative prevalence of behavioral, cognitive, psychiatric, and language symptoms were compared between groups, as was time of symptom onset. Clinical diagnostic criteria for FTD and AD were applied to case histories. Sensitivity and specificity of clinical FTD diagnostic criteria (Report of the Work Group on FTD and Pick's disease) were computed.
RESULTS: Cumulative prevalence of symptoms in HSD was most similar to that of FTD and differed from AD. Behavioral abnormalities such as decreased grooming and inappropriate behavior were more prevalent in HSD and FTD than AD. Hyperorality, inappropriate behavior, and decreased interest had earlier onset in HSD and FTD. Cognitive symptoms of disorientation, dyscalculia, apraxia, and agnosia were more prevalent in AD, as were psychiatric symptoms of hallucinations, delusions, and aggression. Most HSD patients met diagnostic criteria for FTD. Criteria sensitivity was 64.0% and specificity was 73.7%.
CONCLUSIONS: FTD is a clinical syndrome associated with heterogeneous neuropathology. The clinical course of HSD is more similar to that of FTD than AD. These findings, together with the neuropathologic data presented in the accompanying article, support expanding the scope of FTD (Pick complex) to include HSD.

Entities:  

Mesh:

Year:  2004        PMID: 15304580     DOI: 10.1212/01.wnl.0000133008.89613.82

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion.

Authors:  Olga Pletnikova; Kelly L Sloane; Alan E Renton; Bryan J Traynor; Barbara J Crain; Tammy Reid; Tao Zu; Laura P W Ranum; Juan C Troncoso; Peter V Rabins; Chiadi U Onyike
Journal:  Neurobiol Aging       Date:  2014-04-18       Impact factor: 4.673

Review 2.  Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review.

Authors:  A D Hutchinson; J L Mathias
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-19       Impact factor: 10.154

3.  Measures of metabolism provide insights into hippocampal sclerosis.

Authors:  Brian A Gordon
Journal:  Brain       Date:  2018-04-01       Impact factor: 13.501

4.  Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly.

Authors:  Dennis W Dickson; Matthew Baker; Rosa Rademakers
Journal:  Neurodegener Dis       Date:  2010-03-03       Impact factor: 2.977

5.  Hippocampal sclerosis in advanced age: clinical and pathological features.

Authors:  Peter T Nelson; Frederick A Schmitt; Yushun Lin; Erin L Abner; Gregory A Jicha; Ela Patel; Paula C Thomason; Janna H Neltner; Charles D Smith; Karen S Santacruz; Joshua A Sonnen; Leonard W Poon; Marla Gearing; Robert C Green; John L Woodard; Linda J Van Eldik; Richard J Kryscio
Journal:  Brain       Date:  2011-05       Impact factor: 13.501

Review 6.  Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-Related Tauopathy.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Continuum (Minneap Minn)       Date:  2019-02

7.  Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome.

Authors:  Satish C Rao; Gerald Dove; Gregory D Cascino; Ronald C Petersen
Journal:  Epilepsy Behav       Date:  2008-10-08       Impact factor: 2.937

8.  TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study.

Authors:  Kimmo J Hatanpaa; Eileen H Bigio; Nigel J Cairns; Kyle B Womack; Sandra Weintraub; John C Morris; Chan Foong; Guanghua Xiao; Christa Hladik; Tina Y Mantanona; Charles L White
Journal:  J Neuropathol Exp Neurol       Date:  2008-04       Impact factor: 3.685

Review 9.  Understanding hippocampal sclerosis in the elderly: epidemiology, characterization, and diagnostic issues.

Authors:  Chris Zarow; Traci E Sitzer; Helena C Chui
Journal:  Curr Neurol Neurosci Rep       Date:  2008-09       Impact factor: 5.081

10.  Hippocampal and mesial temporal sclerosis in early-onset frontotemporal lobar degeneration versus Alzheimer's disease.

Authors:  Aditi Joshi; Edmond Teng; Kanida Tassniyom; Mario F Mendez
Journal:  Am J Alzheimers Dis Other Demen       Date:  2013-10-01       Impact factor: 2.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.